July 13, 2022
Altis Biosystems to Award a Fully Funded Pilot Project
Altis Biosystems, Inc., developer of RepliGut®, announces a Research Funding Initiative
June 22, 2022
Assessing Drug-induced Gut Toxicity In Vitro
Webinar July 27th 11:00 AM - 12:30 PM
May 12, 2022
Altis named one of the top 20 most innovative organ-on-a-chip companies in the world.
Top 20 most innovative organ-on-a-chip companies
February 3, 2022
Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute
Altis Biosystems, Inc., developer of RepliGut®, a technology platform that produces a layer of human intestinal stem...
January 27, 2022
Altis Biosystems Appoints Jimmy Smedley, Ph.D. Chief Operating Officer
Altis Biosystems, Inc., developer of RepliGut®, a technology platform that produces a layer of human intestinal stem...